SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-190800
Filing Date
2023-07-21
Accepted
2023-07-21 06:04:54
Documents
19
Period of Report
2023-07-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d489429d8k.htm   iXBRL 8-K 36286
2 EX-1.1 d489429dex11.htm EX-1.1 154746
3 EX-4.1 d489429dex41.htm EX-4.1 83062
4 EX-5.1 d489429dex51.htm EX-5.1 15548
5 EX-10.1 d489429dex101.htm EX-10.1 178484
6 EX-99.1 d489429dex991.htm EX-99.1 12333
10 GRAPHIC g489429dsp84.jpg GRAPHIC 10707
11 GRAPHIC g489429g0721064642316.jpg GRAPHIC 2552
  Complete submission text file 0001193125-23-190800.txt   748728

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ibrx-20230720.xsd EX-101.SCH 2862
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibrx-20230720_lab.xml EX-101.LAB 17235
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibrx-20230720_pre.xml EX-101.PRE 10820
13 EXTRACTED XBRL INSTANCE DOCUMENT d489429d8k_htm.xml XML 3228
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

IRS No.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 231101024
SIC: 2836 Biological Products, (No Diagnostic Substances)